Depression Treatment: Incidence and Predictors of Depression in Non-Demented Primary Care Attenders Aged 75 Years and Older: Results From a 3-Year Follow-Up Study.

Incidence and predictors of depression in non-demented primary care attenders aged 75 years and older: results from a 3-year follow-up study.

Filed under: Depression Treatment

Age Ageing. 2013 Jan 11;
Weyerer S, Eifflaender-Gorfer S, Wiese B, Luppa M, Pentzek M, Bickel H, Bachmann C, Scherer M, Maier W, Riedel-Heller SG

OBJECTIVE: to determine incidence and predictors of late-life depression. METHODS: this is a 3-year observational cohort study of 3,214 non-demented patients aged 75 and over completing three waves of assessment. The patients were recruited in 138 primary care practices in six urban areas in Germany. Depressive symptoms were measured at baseline, and 18 months and 36 months later using the GDS-15 Geriatric Depression Scale with a cut-off 0-5/6-15. Cox proportional hazard regression models were applied to examine predictors of incident depression, adjusting for sex, age, education, living situation, activities of daily living – and instrumental activities of daily living impairment, somatic comorbidity, alcohol consumption, smoking, mild cognitive impairment and apoE4 status. RESULTS: the incidence of depression was 36.8 (95% CI: 29.6-45.3) per 1,000 person-years in men and 46.0 (95% CI: 39.9-52.8) in women (sex difference P = 0.069). The incidence increased from 35.4 (95% CI: 29.7-41.9) per 1000 person-years between the ages of 75 and 79 to 75.2 (95% CI: 53.2-103.2) for subjects 85 years and older. After full adjustment for confounding variables, hazard ratios (HR) for incident depression were significantly higher for subjects 85 years and older (HR: 1.83, 95% CI: 1.24-2.70) and those with mobility impairment (HR: 2.53, 95% CI: 1.97-3.25), vision impairment (HR: 1.41, 95% CI: 1.04-1.91), mild cognitive impairment (HR: 1.52, 95% CI: 1.10-2.10), subjective memory impairment (HR: 1.33, 95% CI: 1.01-1.74) and current smoking (HR: 1.69, 95% CI: 1.13-2.53). CONCLUSIONS: the incidence of depression increased significantly with age. In designing prevention programmes, it is important to call more attention on functional impairment, cognitive impairment and smoking.
HubMed – depression


Intimate Partner Violence and Depressive Symptoms Before Pregnancy, During Pregnancy, and After Infant Delivery: An Exploratory Study.

Filed under: Depression Treatment

J Interpers Violence. 2013 Jan 11;
Ogbonnaya IN, Macy RJ, Kupper LL, Martin SL, Bledsoe-Mansori SE

Women who experience intimate partner violence (IPV) during pregnancy also tend to experience depressive symptoms. Unfortunately, little is known about how victimized women’s levels of depressive symptoms change longitudinally before pregnancy, during pregnancy, and after infant delivery. In addition, few studies have used a comparison group of women to determine if levels of depressive symptoms among victimized women differ from depressive symptom levels in women who have not experienced IPV. To help address these knowledge gaps, we examined longitudinal trends in levels of depressive symptoms among a sample of 76 women who did (n = 33) and did not (n = 43) experience physical IPV during pregnancy. Using multilevel analysis, we estimated the relationship of physical IPV victimization and women’s depressive symptom levels across six time periods: (a) the year before pregnancy, (b) first and second trimesters, (c) third trimester, (d) the first month postpartum, (e) Months 2 to 6 postpartum, and (f) Months 7 to 12 postpartum. Women who experienced physical IPV victimization during pregnancy had significantly higher levels of depressive symptoms during each time period (p < .05). No significant difference between the two groups was found in the rate of change in levels of depressive symptoms over time. These findings point to the importance of screening for IPV within health care settings and suggest that women physically abused during pregnancy need safety interventions that are coordinated with interventions targeting symptoms of depression. HubMed – depression


[The relationship between DSM-IV axis II and the anaclitic and introjective personality dimensions].

Filed under: Depression Treatment

Tijdschr Psychiatr. 2013; 55(1): 9-19
Descheemaeker M, Lowyck B, Verhaest Y, Luyten P, Vermote R

In his psychodynamic theory of personality development, Blatt distinguishes between an anaclitic and an introjective cluster of psychological disorders. Whereas, in the past, research in this area has focused mainly on depression, nowadays more and more attention is being given to the relevance of this distinction for the theoretical conceptualisation and treatment of personality disorders (pd).To examine the association between dsm-iv pd characteristics and the anaclitic and introjective personality dimensions.We conducted a cross-sectional study (n = 48) embedded in a five-year follow-up study after psychodynamic treatment for pd. We used multiple linear-regression analysis to investigate the relationship between pd characteristics (scid-ii Personality Questionnaire) and the anaclitic and introjective personality dimensions (Depressive Experiences Questionnaire), while controlling for the severity of the depression (Beck Depression Inventory) and for the introjective and anaclitic dimension, respectively.There was evidence for a positive relationship between the anaclitic dimension and dependent and borderline pd characteristics on the one hand and between the introjective dimension and avoidant, obsessive-compulsive, passive-aggressive, depressive, paranoid, schizotypal and narcissistic pd characteristics on the otherhand.Results are consistent with and provide important empirical support for Blatt’s assumptions concerning an anaclitic and an introjective cluster of personality pathology.
HubMed – depression


Accutane--Is This Acne Drug Treatment Linked to Depression and Suicide? by...

End Date: Thursday Jul-23-2020 4:46:37 PDT
Buy It Now for only: $24.75
Buy It Now | Add to watch list


Depression : Causes and Treatment by Aaron T. Beck
End Date: Tuesday Jul-28-2020 5:35:24 PDT
Buy It Now for only: $4.09
Buy It Now | Add to watch list


Depression Treatment
End Date: Monday Jul-13-2020 23:15:18 PDT
Buy It Now for only: $699.99
Buy It Now | Add to watch list


Related Depression Treatment Information…